Press Release

Another very successful year for the ZEISS Group

The ZEISS Group achieved significant growth across all segments despite challenging geopolitical and economic conditions.

14 December 2022

Significant revenue growth of 8.8 billion euros despite challenging geopolitical and economic conditions – EBIT at 1.6 billion euros (up 109 million euros compared to the prior year). The ZEISS Group once again significantly surpassed the strong prior-year level.

    • All four ZEISS segments have shown double-digit percentage growth
    • Focused investment strategy with high expenditure on research and development (13% of revenue)
    • Headcount rises by 10% to 38,770
    Oberkochen, Germany | 14 December 2022 | ZEISS Group
    The ZEISS Group achieved significant growth across all segments despite challenging geopolitical and economic conditions. Revenue rose by 16% to 8.8 billion euros, surpassing over 8 billion euros for the first time (prior year: 7.5 billion euros) in fiscal year 2021/22 (end of reporting period: 30 September 2022). Earnings before interest and tax (EBIT) also achieved a new peak, reaching 1.6 billion euros (prior year: 1.5 billion euros). The ZEISS Group increased orders significantly by 19% to a new record level of 10.7 billion euros (prior year: 9.0 billion euros).
    "The past year was certainly very difficult and challenging in many places due to the geopolitical conditions. Nevertheless, we can look back on another successful fiscal year with a high degree of economic satisfaction," said Dr. Karl Lamprecht, President and CEO of ZEISS. "For the first time in our history our annual revenue has exceeded the threshold of 8 billion euros. All four ZEISS segments and more than 38,000 employees have contributed to this. We are growing and at the same time investing in the future worldwide. The success shows that we are on the right track with our strategy focused on megatrends."

    Segment development

    Revenue (in million euros)



    (adjusted for currency effects)

    Semiconductor Manufacturing Technology



    +20% (+19%)

    Industrial Quality & Research



    +15% (+10%)

    Medical Technology*



    +15% (+9%)

    Consumer Markets



    +13% (+7%)

    * Not identical to the Carl Zeiss Meditec Group

    The Semiconductor Manufacturing Technology segment achieved record-breaking revenue. The high demand for manufacturing equipment for semiconductor production and, in particular, for deep ultraviolet (DUV) and extreme ultraviolet (EUV) lithography systems continued in fiscal year 2021/22. EUV lithography is the key technology for the semiconductor industry to enable the further miniaturization of microchips. In the future, the next EUV generation, High-NA EUV, will enable the production of more powerful and more energy-efficient chips at lower costs.

    The Industrial Quality & Research segment was in a position to significantly increase revenue. The high investments by the automotive industry in alternative drive technologies in particular contributed to this within the field of industrial quality assurance. Demand for optical metrology and software products also developed positively. Microscopy systems for research and science business continued to develop positively compared to the previous year and grew in all regions during the reporting period. Demand increased in the area of X-ray microscopes and in the areas of light and electron microscopy as well as in the service business.

    The ZEISS Medical Technology segment also achieved a significant increase in revenue. Positive development of the product mix with a high proportion of consumables and recurring sales, strong demand in the instrument business and the high order intake are contributing to a positive trend in this business despite strained supply chains. Investments in future technologies through acquisitions, shareholdings and partnerships are further progressing.

    Revenue in the Consumer Markets segment also increased year-on-year in fiscal year 2021/22. The Vision Care strategic business unit generated growth in all regions - particularly with ZEISS brand lenses, innovations and digital products. With innovations and greater market penetration, revenue for nature observation and hunting optics are also developing positively. With the resumption of the cine lens business in the reporting period, business with film lenses also grew compared to the previous year.

    Dr. Karl Lamprecht, CEO of Carl Zeiss AG

    Dr. Karl Lamprecht, CEO of Carl Zeiss AG

    Dr. Christian Müller, CFO of Carl Zeiss AG

    Dr. Christian Müller, CFO of Carl Zeiss AG

    Key figures

    Group equity rose by 30.6% to 7.173 billion euros in comparison with fiscal year end 2020/21 (prior year: 5.494 billion euros), corresponding to an equity ratio of 55% (prior year: 52%).

    The ZEISS Group continues on its dynamic growth trajectory and is banking on innovative strength for the future. The expenditure for research and development was increased and amounted to 1,151 million euros at around 13% of revenue (prior year: 943 million euros). At R&D departments across the ZEISS Group, more than 5,200 employees are working on further expanding the company's innovative strength. This is reflected in the number of patents which totaled around 10,500 worldwide as of the reporting date.

    Significant revenue growth was generated in the APAC region (+22%), while the Americas and EMEA regions also recorded sales growth. Thus, all regions continue to be on a good growth track and have again contributed to the positive development of ZEISS.

    "One of the factors behind our success is our focused investment strategy. The continuing high level of expenditure on research and development, which amounts to 13% of revenue, is our investment in the future - at 1,151 million euros, it has reached a new high," said Dr. Christian Müller, CFO of Carl Zeiss AG. "Sustainability plays a major role for us. A commitment to the common good and to finding solutions for key societal issues are part and parcel of our ethos,” added Müller.

    In addition to the high expenditure on research and development, ZEISS is making targeted investments in the expansion of infrastructure, not only at its main site in Oberkochen but also in Jena, Wetzlar, Dresden and at other sites in Germany and worldwide, e.g. in India. The company is thus accommodating the accelerated growth. The targeted expansion of infrastructure will safeguard the long-term competitive and innovative edge through research, production and development capacities.

    ZEISS had a global workforce of 38,770 employees (prior year: 35,375 employees) at the reporting date of 30 September 2022. Headcount thus increased by 10% as compared to 30 September 2021.


    The macroeconomic environment continues to be characterized by a high degree of uncertainty, with a strong impact on the global economic cycles. "We are monitoring developments and the associated risks very closely and are preparing ourselves as much as possible to be able to respond to new situations and challenges quickly and effectively. We continue to assess the ZEISS Group's business development for fiscal year 2022/23 as positive," Lamprecht concluded.


    Further information

    Press contact Jörg Nitschke

    Head of Corporate Brand, Communications and Public Affairs
    ZEISS Group

    About ZEISS

    ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 8.8 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (updated: 30 September 2022).

    For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, as well as medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

    With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13% of its revenue in research and development work – ZEISS has a long tradition of high expenditure in these areas. This also represents the company's investment in the future.

    With over 38,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (updated: 30 September 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG

    Further information at

    Press photos

    • Dr. Karl Lamprecht, President and CEO of Carl Zeiss AG

      President and CEO of Carl Zeiss AG

      File size: 296 KB
    • Dr. Karl Lamprecht

      CEO of Carl Zeiss AG

      File size: 9 MB
    • Dr. Christian Müller

      Chief Financial Officer of the ZEISS Group

      File size: 2 MB
    • Executive Board of Carl Zeiss AG

      File size: 2 MB
    • ZEISS microscope developers nominated for 2022 German Future Prize

      File size: 2 MB
    • ZEISS mirror for the next EUV generation

      ZEISS mirror for the next EUV generation (High-NA-EUV lithography) suspended on an crane in front of a measuring technology system

      File size: 1 MB